Off-label Indications
1 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Managed Access Programs for CTL019, Tisagenlecleucel (NCT03601442) | Novartis Pharmaceuticals |
Track Off-label Indications automatically
Every clearance here is in the API, with alerts when new ones post.